Trends - GSK - Business Recorder

GSK

GSK-Vir therapy has neutralising activity against Omicron sub-variant, data shows

LONDON: An antibody-based COVID-19 therapy developed by GSK and Vir Biotechnology retains neutralising activity...

Published 10 Feb, 2022 12:25pm

World

AstraZeneca sees 2022 growth, but COVID boost to drop

AstraZeneca on Thursday forecast higher 2022 sales after the drugmaker posted better-than-expected fourth-quarter...

Published 10 Feb, 2022 12:23pm

Business & Finance

GSK's COVID-related sales close to $2bn, profit boost to wane in 2022

GSK racked up 1.4 billion pounds ($1.9 billion) in COVID-related sales in 2021, largely for antibody drug ...

Published 09 Feb, 2022 12:46pm

Markets

Oil stocks, GSK weakness pull FTSE 100 lower; Deliveroo jumps

• Deliveroo fourth-quarter order growth jumps • Premier Foods top midcap gainer on strong profit outlook •...

Published 21 Jan, 2022 05:27am

Markets

Unilever's strategy in spotlight after dropping $68 billion GSK battle

Unilever's strategy was under the investor microscope on Thursday after the consumer goods giant effectively...

Published 20 Jan, 2022 07:52pm

Business & Finance

Unilever won't up £50bn offer for GSK-Pfizer unit

LONDON: Consumer goods giant Unilever on Wednesday said it would not increase a £50-billion offer for the consumer...

Published 19 Jan, 2022 11:26pm

Markets

FTSE 100 hits two-year high as GSK boosts

LONDON: London’s FTSE ended higher on Monday, aided by healthcare stocks as GlaxoSmithKline jumped after rejecting...

Published 18 Jan, 2022 04:20am

Business & Finance

European stocks rise tracking big corporate news, China growth

LONDON: European stock markets advanced Monday, with traders focusing on slowing Chinese growth and a potential...

Published 17 Jan, 2022 06:44pm

Business & Finance

Unilever pursues GSK-Pfizer unit after huge bid rebuffed

LONDON: Consumer goods giant Unilever on Monday revealed ongoing interest in a consumer health care unit owned by...

Published 17 Jan, 2022 02:41pm

Business & Finance

GSK rejects 50-billion-pound Unilever offer for consumer assets

Unilever earlier confirmed the approach

Published 15 Jan, 2022 10:33pm

Unilever offered 50bn pounds for GSK unit: report

LONDON: Consumer goods giant Unilever made a bid towards the end of last year for pharmaceutical group...

Published 15 Jan, 2022 04:35pm

Markets

Aussie buoyant, dollar listless as Omicron optimism lifts risk assets

TOKYO: The Australian dollar hit its strongest level in a week on Wednesday amid a pick-up in risk appetite on signs...

Published 08 Dec, 2021 09:58am

World

New data shows GSK-Vir drug works against all Omicron mutations

British drugmaker GSK said on Tuesday its antibody-based COVID-19 therapy with US partner Vir Biotechnology is...

Published 07 Dec, 2021 02:26pm

Business & Finance

GSK's drugs arm to get $11bn windfall from consumer spin-off

GSK consumer arm to be demerged in middle of 2022.
Drugs business to get 8 bln stg dividend from consumer arm.
Lower debt ratio, dividend to boost finances of drugs arm.

Published 23 Jun, 2021 05:50pm

Business & Finance

Study confirms GSK-Vir antibody drug reduces hospitalization, death in COVID-19 patients

In a study of 1,057 patients, sotrovimab resulted in a 79% reduction in risk of hospitalization for more than 24 hours or death due to any cause, the companies said on Monday.
Similar therapies developed by rivals Regeneron and Eli Lilly have been approved by US regulators for treating non-hospitalized COVID-19 patients.

Published 21 Jun, 2021 05:31pm

Business & Finance

Britain's GSK exits US drugmaker Innoviva in $392mn deal

The London-listed company said it sold roughly 32 million shares in the Nasdaq-listed Innoviva for $12.25 per share, a marginal discount to the stock's closing price of $12.29 on Wednesday.
Shares of GSK were 0.3% lower at 1,361.3 pence by 1427 GMT, while Innoviva gained 5.1% to about $13.

Published 20 May, 2021 09:16pm

World

Left-behind Sanofi closes in on Covid vaccine

PARIS: French pharmaceuticals giant Sanofi on Monday reported positive results in trials of its belated Covid-19 ...

Updated 18 May, 2021 09:36am

BR Research

GlaxoSmithKline Pakistan Limited

GlaxoSmithKline Pakistan Limited (PSX: GLAXO) was set up through a merger of three companies, SmithKline and French...

Published 30 Apr, 2021 07:45am

Business & Finance

GSK focused on split as cost checks, COVID-19 easings aid earnings

CEO says focused on seeing split through, big picture.
COVID-19 pandemic still taking toll on overall business.
GSK expects recovery in vaccine sales in H2.
Shares marginally higher following Q1 results release.

Published 28 Apr, 2021 08:35pm

Business & Finance

France's Sanofi to help Moderna manufacture COVID-19 shots

Sanofi said it would help supply up to 200 million doses of Moderna's vaccine at its Ridgefield facility in New Jersey. Financial details of the arrangement were not disclosed.
A month later, it said it would fill and finish vials of Johnson & Johnson's single-shot vaccine at a rate of approximately 12 million doses per month.

Published 26 Apr, 2021 05:31pm

World

GSK to produce 60m Novavax doses for Britain

LONDON: GlaxoSmithKline is to manufacture 60 million doses of the Covid-19 vaccine developed by US biotech company...

Published 30 Mar, 2021 05:45am

World

GSK to fill up to 60mn Novavax vaccine doses for Britain

Novavax will manufacture some of the vaccine using Fujifilm Diosynth Biotechnologies facilities in Stockton-on-Tees, northern England.

Published 30 Mar, 2021 12:07am

Business & Finance

Vir, GSK plan to seek emergency use nod for COVID-19 antibody therapy

Antibody treatments are designed to decrease the severity of COVID-19 among patients diagnosed with the infection.

Published 11 Mar, 2021 11:16am

Business & Finance

GSK narrows focus on elderly in trial to treat pneumonia from COVID-19

A trial started in May last year has shown that the drug known as otilimab helps patients over 70 with severe COVID-19 get off mechanical ventilation or high-flow oxygen support faster.
The benefit for younger trial participants was not clear enough to merit further investigation, prompting the re-focus on the elderly in a follow-up trial with a targeted 350 participants.

Published 25 Feb, 2021 07:08pm

Business & Finance

GSK, Vir Biotech to expand COVID-19 research partnership for other diseases

The companies will research monoclonal antibody treatments for influenza and other respiratory illnesses as a part of the agreement.
As a part of the deal, GSK will make a further $120 million equity investment in Vir and will pay the company an additional upfront payment of $225 million.

Published 17 Feb, 2021 05:58pm

Business & Finance

GSK recognised as top employer in Pakistan

KARACHI: The Top Employers Institute has announced the 2021 Top Employers and named GSK as top Employer in ...

Updated 12 Feb, 2021 11:46pm

Business & Finance

GSK Consumer Health Pakistan appoints Farhan Muhammad Haroon as CEO

*The company informed that the incoming Farhan Muhammad Haroon will assume the charge of the company effective 1 April 2021.

Published 08 Feb, 2021 04:58pm

World

EU concludes preliminary talks to buy up to 200mn doses of Novavax COVID vaccine

The possible deal with Novavax would be the seventh sealed by the EU with vaccine makers for the supply of COVID-19 shots.

Published 17 Dec, 2020 04:35pm

World

Sanofi, GSK Covid vaccine to be ready only at the end of 2021

Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine programme.

Published 11 Dec, 2020 12:12pm

Business & Finance

GSK warns COVID-19 will dent full-year earnings

GSK shares were down 1% at 1,347.2 pence after the drugmaker's shingles vaccine Shingrix, the biggest driver of sales growth last year, saw quarterly revenue fall 30% from a year earlier.
What we saw through the quarter ... were definitely lower vaccination rates in July and August.

Updated 28 Oct, 2020 08:51pm

Forex
World
Commodity

Currency	Rate
USD PKR Interbank Selling / May 10	278.14
USD PKR Interbank Buying / May 10	277.97
USD to Japanese Yen / May 10	155.70
USD to Swiss Franc / May 10	0.91
Pound Sterling to USD / May 10	1.25
Euro to USD / May 10	1.08

Stock	Volume
S&P 500 / May 9	5214.08
Nasdaq / May 9	16346.27
Dow Jones / May 9	39387.76
India Sensex / May 10	72468.66
Tokyo Nikkei / May 10	38229.11
Hang Seng / May 10	18970.69
FTSE 100 / May 10	8438.19
Germany DAX 30 / May 10	18827.29

Item	Value
Crude Oil USD/Barrel / May 10	79.87
Karachi Cotton PKR/37.32 KG / May 10	19935
Gold 10 Grams PKR / May 10	209019
Gold Spot USD/Ounce / May 10	2369.35
Cotton US¢/pound / May 10	78.18
Petrol/Litre / May 11	288.49

Gainers
Losers
Leaders

Stock	Price
786 Invest Ltd / May 11 786 Investments Limited(786)	5 ▼ 0.00 (0.00%)
AL-Abbas Sugar / May 11 Al-Abbas Sugar Mills Limited(AABS)	585 ▼ 0.00 (0.00%)
Agro Allianz / May 11 Agro Allianz Limited(AAL)	16 ▼ 0.00 (0.00%)
AL-Abid Silk / May 11 Al-Abid Silk Mills Limited(AASM)	3.49 ▼ 0.00 (0.00%)
Ali Asghar / May 11 Ali Asghar Textile Mills Limited(AATM)	2.07 ▼ 0.00 (0.00%)
Allied Bank / May 11 Allied Bank Limited(ABL)	87.10 ▼ 0.00 (0.00%)
Abbott Lab. / May 11 Abbott Laboratories (Pakistan) Limited(ABOT)	499.34 ▼ 0.00 (0.00%)
Abson Ind. / May 11 Abson Industries Limited(ABSON)	2.50 ▼ 0.00 (0.00%)
Alfalah ETF. / May 11 Alfalah Consumer Index ETF.(ACIETF)	9.84 ▼ 0.00 (0.00%)

Stock	Price
786 Invest Ltd / May 11 786 Investments Limited(786)	5 ▲ 0.00 (0.00%)
AL-Abbas Sugar / May 11 Al-Abbas Sugar Mills Limited(AABS)	585 ▲ 0.00 (0.00%)
Agro Allianz / May 11 Agro Allianz Limited(AAL)	16 ▲ 0.00 (0.00%)
AL-Abid Silk / May 11 Al-Abid Silk Mills Limited(AASM)	3.49 ▲ 0.00 (0.00%)
Ali Asghar / May 11 Ali Asghar Textile Mills Limited(AATM)	2.07 ▲ 0.00 (0.00%)
Allied Bank / May 11 Allied Bank Limited(ABL)	87.10 ▲ 0.00 (0.00%)
Abbott Lab. / May 11 Abbott Laboratories (Pakistan) Limited(ABOT)	499.34 ▲ 0.00 (0.00%)
Abson Ind. / May 11 Abson Industries Limited(ABSON)	2.50 ▲ 0.00 (0.00%)
Alfalah ETF. / May 11 Alfalah Consumer Index ETF.(ACIETF)	9.84 ▲ 0.00 (0.00%)

Stock	Volume
P.I.A.C.(A) / May 11 Pakistan International Airlines Corp(PIAA)	47,200,500 ▲ 0.00
Cnergyico PK / May 11 Cnergyico PK Limited(CNERGY)	29,719,327 ▲ 0.00
Pak Petroleum / May 11 Pakistan Petroleum Limited(PPL)	21,170,581 ▲ 0.00
Pak Refinery / May 11 Pakistan Refinery Limited(PRL)	16,965,134 ▲ 0.00
The Searle Co. / May 11 The Searle Company Limited(SEARL)	15,793,227 ▲ 0.00
P.T.C.L. / May 11 Pakistan Telecommunication Company Ltd(PTC)	15,054,641 ▲ 0.00
K-Electric Ltd. / May 11 K-Electric Limited(KEL)	14,145,556 ▲ 0.00
WorldCall Telecom / May 11 Worldcall Telecom Limited(WTL)	13,158,668 ▲ 0.00
Telecard Limited / May 11 Telecard Limited(TELE)	12,358,668 ▲ 0.00

Markets →

Calculate your monthly liability in FY24

GSK

Most Popular